Active substance
Nalidixic acid
- SFDA 4
- US FDA 8
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ACIDO NALIDIXICO 500 MG TAB | 500 mg | Tablet · Oral use | 56 Blister | SAR 26.85 | NCE · Prescription | ALMIRALL PRODES PHARMA S.A. | Withdrawn by MAH · Not Marketed |
| ACIDO NALIDIXICO SUSP.125MG-5ML | 25 mg/ml | Syrup · Oral use | 1 Bottle | SAR 7.30 | NCE · Prescription | ALMIRALL PRODES PHARMA S.A. | Withdrawn by MAH · Not Marketed |
| NALIDRAM TAB | 500 mg | Tablet · Oral use | 20 Blister | SAR 10.35 | Generic · Prescription | MEMPHIS CHEMICALS | Withdrawn by regulatory authority · Not Marketed |
| NEGRAM 500MG TAB | 500 mg | Tablet · Oral use | 56 Blister | SAR 47.10 | Generic · Prescription | SANOFI-SYNTHLABO | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NEGGRAM | 250MG; 500MG; 1GM | tablet · oral | SANOFI AVENTIS US | Discontinued | 6 Mar 1964 |
| NEGGRAM | 250MG/5ML | suspension · oral | SANOFI AVENTIS US | Discontinued | 17 Apr 1973 |
| NALIDIXIC ACID | 250MG | tablet · oral | SUN PHARM INDUSTRIES | Discontinued | 28 Mar 1986 |
| NALIDIXIC ACID | 1GM | tablet · oral | SUN PHARM INDUSTRIES | Discontinued | 28 Mar 1986 |
| NALIDIXIC ACID | 500MG | tablet · oral | SUN PHARM INDUSTRIES | Discontinued | 29 Mar 1986 |
| NALIDIXIC ACID | 1GM | tablet · oral | WATSON LABS | Discontinued | 28 Jun 1988 |
| NALIDIXIC ACID | 250MG | tablet · oral | WATSON LABS | Discontinued | 28 Jun 1988 |
| NALIDIXIC ACID | 500MG | tablet · oral | WATSON LABS | Discontinued | 28 Jun 1988 |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.